GERON
Geron Corp. operates as a biopharmaceutical company which discovers and develops therapeutic products for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is a product candidate in clinical development.
GERON
Social Links:
Industry:
Biopharma Biotechnology Health Diagnostics Pharmaceutical
Founded:
1990-08-28
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.geron.com
Total Employee:
101+
Status:
Active
Contact:
6504737718
Email Addresses:
[email protected]
Total Funding:
361.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Apache Microsoft Exchange Online
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Geron
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Geron
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Geron
Venrock
Venrock investment in Seed Round - Geron
Key Employee Changes
Official Site Inspections
http://www.geron.com Semrush global rank: 397.72 K Semrush visits lastest month: 140.19 K
- Host name: a545f4e6291a32fb6.awsglobalaccelerator.com
- IP address: 52.223.28.213
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Geron"
Our tireless pursuit - Geron
Powered by pioneering science, grounded in world-class expertise, and driven by purpose, Geron aims to change lives by changing the course of blood cancer. Nobel Prize-winning discoveries about an enzyme called telomerase and its …See details»
Geron Corporation - Wikipedia
Geron, based in Foster City, California, was founded by gerontologist Mary C. West and Michael D. West, now CEO of AgeX Therapeutics. They secured initial venture capital investments in the company from Kleiner Perkins Caufield & Byers and Venrock. The company was incorporated in 1990 and began doing business in 1992. John A. Scarlett was appointed CEO in 2011. The company's Scientific and Clinical Advisory Board has included Nobel laureates James WatsonSee details»
Geron Corporation - Investors & Media
Nov 11, 2024 Geron is a commercial-stage biopharmaceutical company with a first-in-class telomerase inhibitor that is approved in the United States for the treatment of certain adult patients with lower-risk myelodysplastic syndromes …See details»
Geron - Crunchbase Company Profile & Funding
Geron is a biotechnology company that specializes in developing blood cancer treatments for hematologic malignancies. The company's Imetelstat, an investigational first-in-class telomerase inhibitor, harnesses Nobel Prize …See details»
Contact us - Geron
Corporate Headquarters. 919 E. Hillsdale Blvd, Suite 250 Foster City, CA 94404 (650) 473-7700See details»
Geron Corporation - LinkedIn
Geron is a biopharmaceutical company that is charting a new course with the goal to deliver innovative treatment options for people living with blood cancer.See details»
Geron - The Org
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic …See details»
Geron Corporation - Geron Corporation Reports Third Quarter …
Nov 7, 2024 FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course …See details»
Leadership Team - Team at Geron - The Org
Geron's Leadership Team includes Olivia K. Bloom and 7 others. Edit team. Team members. Andrew J. Grethlein EVP & COO. Anil Kapur EVP, Corporate Strategy & Chief Commercial …See details»
Geron Corporation Announces Appointment of Joseph Eid, M.D. as ...
Nov 11, 2024 Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced …See details»
Our story continues to evolve - Geron
For more than 30 years, Geron has tirelessly dedicated itself to the pursuit of new therapies for patients with blood cancers ... Elizabeth H. Blackburn – Facts (nobelprize.org). Accessed …See details»
Geron Corporation (GERN) - Yahoo Finance Canada
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops …See details»
Geron to Participate in the 7th Annual Evercore ISI HealthCONx …
1 day ago FOSTER CITY, Calif., November 27, 2024--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that members of the …See details»
Geron Corporation Announces Appointment of Jim Ziegler as …
Sep 9, 2024 Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, announced the …See details»
Geron
Scientific study of aging: The Gerontological Society of America (GSA) is a leading, forward-thinking interdisciplinary organization devoted to research, education, advocacy and practice …See details»
Geron Corporation - Geron Corporation Reports Fourth Quarter …
Mar 10, 2022 Top-Line Results from IMerge Phase 3 Trial in Lower Risk MDS Expected in Early January 2023 Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical …See details»
Careers | Geron
In addition, Geron’s internal recruiting staff sends interview appointments and email communications to candidates from “@geron.com” email accounts only. Any email that …See details»
Geron Corporation - Geron to Participate in the 7th Annual …
2 days ago Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that members of the management team are scheduled to …See details»
Our commitment to patients | Geron
To learn about our clinical trials, click here. To see clinical trials that are currently underway and to find out if a study is enrolling patients with your condition and in your area, please visit …See details»